The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients.
暂无分享,去创建一个
J. Spertus | J. Mahnken | E. Ellerbeck | S. Rigler | J. Wetmore | T. Shireman | P. Mukhopadhyay | Q. Hou
[1] W. Winkelmayer,et al. The increasing prevalence of atrial fibrillation among hemodialysis patients. , 2011, Journal of the American Society of Nephrology : JASN.
[2] Lorien S Dalrymple,et al. Infection-related hospitalizations in older patients with ESRD. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] P. Kerr,et al. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. , 2010, Kidney international.
[4] R. Foley,et al. Mortality from Cancer among US Hemodialysis Patients, 1995–2005 , 2010, American Journal of Nephrology.
[5] S. Seliger. Comorbidity and confounding in end-stage renal disease. , 2010, Kidney international.
[6] Zhi Huang,et al. An improved comorbidity index for outcome analyses among dialysis patients. , 2010, Kidney international.
[7] J. Wheeler,et al. Provider monitoring and pay-for-performance when multiple providers affect outcomes: An application to renal dialysis. , 2009, Health services research.
[8] R. Thadhani,et al. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. , 2009, Journal of the American Society of Nephrology : JASN.
[9] R. Foley,et al. Hemodialysis access at initiation in the United States, 2005 to 2007: Still “Catheter First” , 2009, Hemodialysis international. International Symposium on Home Hemodialysis.
[10] P. Castellano,et al. Atrial fibrillation in incident dialysis patients. , 2009, Kidney international.
[11] D. Levy,et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study , 2009, The Lancet.
[12] J. Klein,et al. Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] Tong Liu,et al. Atrial Fibrillation in End‐Stage Renal Disease , 2007, Pacing and clinical electrophysiology : PACE.
[14] K. Kalantar-Zadeh,et al. CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Introduction: The Reverse Epidemiology Controversy , 2007, Seminars in dialysis.
[15] K. Kalantar-Zadeh. CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: What Is So Bad about Reverse Epidemiology Anyway? , 2007, Seminars in dialysis.
[16] A. Schoolwerth,et al. Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[17] J. Menzin,et al. Warfarin Exposure and the Risk of Thromboembolic and Major Bleeding Events Among Medicaid Patients with Atrial Fibrillation , 2006, The Annals of pharmacotherapy.
[18] A. Luke,et al. Increasing body mass index and obesity in the incident ESRD population. , 2006, Journal of the American Society of Nephrology : JASN.
[19] A. Yıldırır,et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. , 2006, International journal of cardiology.
[20] M. Valsecchi,et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] Yuchiao Chang,et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.
[22] J. Pankow,et al. Prediction of coronary heart disease in middle-aged adults with diabetes. , 2003, Diabetes care.
[23] Yuchiao Chang,et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. , 2003, The New England journal of medicine.
[24] A. Folsom,et al. Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. , 2003, Journal of clinical epidemiology.
[25] B. Kestenbaum,et al. Elevated risk of stroke among patients with end-stage renal disease. , 2003, Kidney international.
[26] S. Suissa. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. , 2003, American journal of respiratory and critical care medicine.
[27] Allen J. Taylor,et al. Atrial fibrillation in chronic dialysis patients in the United states: risk factors for hospitalization and mortality , 2003, BMC Nephrology.
[28] Martha J. Radford,et al. Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .
[29] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[30] M. Borrego,et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. , 2000, American heart journal.
[31] D. Di Landro,et al. Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. , 2000, Clinical nephrology.
[32] D. Singer,et al. Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 1999, Annals of Internal Medicine.
[33] D. Levy,et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.
[34] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[35] N. Nakanishi,et al. Electrocardiographic abnormalities in patients receiving hemodialysis. , 1996, American heart journal.
[36] Elsayed Z Soliman,et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). , 2011, The American journal of cardiology.
[37] Ross Ward,et al. United States Renal Data System , 2011 .
[38] J. Mahnken,et al. Considering health insurance: how do dialysis initiates with Medicaid coverage differ from persons without Medicaid coverage? , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[39] David C. Murray,et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. , 1995, Kidney international.